This is great news, but families can't just hand over the nasal spray form to their school nurse. The Texas law allowing ...

Neffy (epinephrine nasal spray) 1mg is approved for the emergency treatment of type 1 allergic reactions, including ...

An adrenaline rush is a colloquial expression about the feeling of exhilaration and heightened energy that is brought on by ...

The US Food and Drug Administration (FDA) has approved Neffy, a nasal spray for treating severe allergic reactions in ...

Whether finding new treatments for schizophrenia or first-time ways to tackle bladder cancer, these companies are finding ...

Sophomores at Lynnfield High School presented their Civics Action projects to community members, who were welcomed into the ...

Aquestive's Anaphylm, which is set for an imminent FDA filing, has blockbuster potential. See why I think AQST stock is a buy ...

$7.3 million in total neffy ® (epinephrine nasal spray) U.S. net product revenue in 2024 since launch in late September 2024 neffy 1 mg approved by U.S. FDA for children aged four and older and ...

ARS Pharmaceuticals, Inc.’s SPRY share price has surged by 19.57%, which has investors questioning if this is right time to ...

The maker of a new prescription drug product for people with life-threatening allergies is using copayment coupons to build ...

Research analysts at Leerink Partnrs dropped their FY2028 EPS estimates for ARS Pharmaceuticals in a research note issued to ...

(MENAFN- GlobeNewsWire - Nasdaq) $7.3 million in total neffy ® (epinephrine nasal spray) U.S. net product revenue in 2024 since launch in late September 2024 neffy 1 mg approved by U.S. FDA for ...